22ND CENTURY GROUP, INC.

Profile

Company Names

22ND CENTURY GROUP, INC.

Addresses

321 FARMINGTON ROAD, MOCKSVILLE, NC 24028

500 SENECA STREET, SUITE 507, BUFFALO, NY 14204

9530 MAIN STREET, CLARENCE,, NY 14031

9530 MAIN STREET, CLARENCE, NY 14031

Phone Numbers

716-270-1523
(716) 270-1523

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

NEVADA

Total Amount Raised:

$116,089,126.00

Number of Funding Rounds:

10
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
10
2024-09-27 
$1,200,000.00 
$1,200,000.00 
$0.00 
Equity 
9
2024-04-08 
$4,200,000.00 
$4,200,000.00 
$0.00 
Equity 
8
2022-07-21 
$35,000,009.00 
$35,000,009.00 
$0.00 
Equity 
7
2022-05-13 
$58,003,000.00 
$58,003,000.00 
$0.00 
Equity 
6
2014-09-17 
$10,000,000.00 
$10,000,000.00 
$0.00 
Equity 
5
2013-01-16 
$67,200.00 
$67,200.00 
$0.00 
Equity 
4
2012-11-09 
$2,428,500.00 
$2,428,500.00 
$0.00 
Equity 
3
2012-08-09 
$530,000.00 
$530,000.00 
$0.00 
Debt 
2
2012-05-15 
$2,734,167.00 
$2,734,167.00 
$0.00 
Equity 
1
2011-12-14 
$1,926,250.00 
$2,012,500.00 
$86,250.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ANDY 
 
ARNO 
DIRECTOR
JOHN T. 
 
BRODFUEHRER 
EXECUTIVE OFFICER
JAMES 
W. 
CORNELL 
DIRECTOR
JOSEPH 
ALEXANDER 
DUNN 
DIRECTOR
LAWRENCE 
 
FIRESTONE 
EXECUTIVE OFFICER, DIRECTOR
CLIFFORD 
B. 
FLEET 
DIRECTOR
JOHN 
 
FRANZINO 
EXECUTIVE OFFICER
THOMAS 
L. 
JAMES 
EXECUTIVE OFFICER
STAFFELDT 
P. 
JONATHAN 
EXECUTIVE OFFICER
STEVEN 
 
KATZ 
DIRECTOR
HUGH 
 
KINSMAN 
EXECUTIVE OFFICER
MICHAEL 
 
KOGANOV 
DIRECTOR
JAMES 
MISH 
DIRECTOR, EXECUTIVE OFFICER
JAMES 
A. 
MISH 
EXECUTIVE OFFICER, DIRECTOR
MICHAEL 
R. 
MOYNIHAN 
EXECUTIVE OFFICER
ROGER 
D. 
O-BRIEN 
DIRECTOR
DANIEL 
 
OTTO 
EXECUTIVE OFFICER
DANIEL 
OTTO 
EXECUTIVE OFFICER
JOSEPH 
NMN 
PANDOLFINO 
EXECUTIVE OFFICER, DIRECTOR
STEVEN 
 
PRZYBYLA 
EXECUTIVE OFFICER
C. 
ANTHONY 
RIDER 
EXECUTIVE OFFICER
LUCILLE 
S. 
SALHANY 
DIRECTOR
RICHARD 
M. 
SANDERS 
DIRECTOR
HENRY 
NMN 
SICIGNANO, III 
EXECUTIVE OFFICER, DIRECTOR
NORA 
B. 
SULLIVAN 
DIRECTOR
MICHAEL 
 
ZERCHER 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
CIGARETTES [2111] 
$5,000,001 - $25,000,000 
Equity 
2024-09-27 
D
BIOTECHNOLOGY 
CIGARETTES [2111] 
$5,000,001 - $25,000,000 
Equity 
2024-04-08 
D
BIOTECHNOLOGY 
CIGARETTES [2111] 
DECLINE TO DISCLOSE 
Equity 
2022-07-21 
D/A
BIOTECHNOLOGY 
CIGARETTES [2111] 
DECLINE TO DISCLOSE 
Equity 
2022-05-13 
D
BIOTECHNOLOGY 
CIGARETTES [2111] 
DECLINE TO DISCLOSE 
Equity 
2022-05-13 
D
BIOTECHNOLOGY 
CIGARETTES [2111] 
DECLINE TO DISCLOSE 
Equity 
2014-09-17 
D
BIOTECHNOLOGY 
CIGARETTES [2111] 
DECLINE TO DISCLOSE 
Equity 
2013-01-16 
D
BIOTECHNOLOGY 
CIGARETTES [2111] 
DECLINE TO DISCLOSE 
Equity 
2012-11-09 
D
BIOTECHNOLOGY 
CIGARETTES [2111] 
DECLINE TO DISCLOSE 
Debt 
2012-08-09 
D
BIOTECHNOLOGY 
CIGARETTES [2111] 
DECLINE TO DISCLOSE 
Equity 
2012-05-15 
D
BIOTECHNOLOGY 
CIGARETTES [2111] 
DECLINE TO DISCLOSE 
Debt 
2011-12-14 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
DAWSON JAMES SECURITIES, INC.
NONE
NONE
DAWSON JAMES SECURITIES, INC.
NONE
NONE
NONE
CHARDAN CAPITAL MARKETS, LLC